Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Alcohol-associated Liver Disease
Questions discussed in this category
Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?
1 Answer available
What precautions should be taken when discharging a patient from the medical setting on new medication assisted therapy for alcohol use disorder?
This is based on the recent publication by Bernstein et al., PMID 38551564 which investigated the increased rate of initiation of MAUD in the hospital...
5 Answers available
23705
20828
Papers discussed in this category
Scientific reports, 2023 Nov 28
Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity.
JCI insight, 2023 Jun 22
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission.
Related Topics
Hepatology
Rheumatology
General Rheumatology
General Internal Medicine
Psychiatry
Addiction Psychiatry
Hospital Medicine
Gastroenterology
General Hepatology
Primary Care